These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1631808)

  • 1. Coupled D dimer and fibrinogen levels during thrombolytic therapy of venous thromboembolism.
    Jude B; Amrouni N; Deguine I; Marey A; Asseman P; Watel A; Thery C; Marache P; Cosson A
    Thromb Res; 1992 Feb; 65(3):457-62. PubMed ID: 1631808
    [No Abstract]   [Full Text] [Related]  

  • 2. Evolution of plasma specific fibrin degradation products during thrombolytic therapy in patients with thrombo-embolism.
    Faivre R; Mirshahi M; Ducellier D; Soria C; Soria J; Mirshahi M; Kieffer Y; Bassand JP; Caen J; Maurat JP
    Thromb Res; 1988 May; 50(4):583-9. PubMed ID: 3413720
    [No Abstract]   [Full Text] [Related]  

  • 3. Impaired resolution of massive pulmonary embolism associated with an inhibited fibrinolytic response.
    Deitcher SR; Lucore CL; Eisenberg PR
    Am J Med; 1994 May; 96(5):483-4. PubMed ID: 8192182
    [No Abstract]   [Full Text] [Related]  

  • 4. Acyl-enzymes as thrombolytic agents in dog models of venous thrombosis and pulmonary embolism.
    Dupe RJ; English PD; Smith RA; Green J
    Thromb Haemost; 1984 Apr; 51(2):248-53. PubMed ID: 6234676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Late results following fibrinolysis therapy of venous thromboses].
    Breddin HK
    Internist (Berl); 1984 Feb; 25(2):102-7. PubMed ID: 6368451
    [No Abstract]   [Full Text] [Related]  

  • 6. Late activation of the fibrinolytic system in myocardial infarction treated with thrombolytic therapy. Influence of the coronary anatomical substrate.
    Salvioni A; Perego GB; Marenzi G; Lauri G; Giraldi F; Grazi S; Guazzi MD
    Eur Heart J; 1996 Feb; 17(2):230-6. PubMed ID: 8732376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biological surveillance of streptokinase treatment].
    Juhan I; Sampol J; Léonetti J; Mathieu P; Muratore R; Serradimigni A
    Coeur Med Interne; 1978; 17(1):49-55. PubMed ID: 639488
    [No Abstract]   [Full Text] [Related]  

  • 8. Thrombolytic therapy for acute deep venous thrombosis: how much is enough?
    Comerota AJ; Katz ML; White JV
    Cardiovasc Surg; 1996 Feb; 4(1):101-4. PubMed ID: 8634837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Measurements of plasmin-alpha 2 plasmin inhibitor complex and FDP.D dimer levels in the fibrinolytic therapy of acute pulmonary thromboembolism].
    Yamasawa F; Hasegawa N; Asano K; Sayama K; Fujita H; Urano T; Aoki T; Ishizaka A; Kanazawa M; Kawashiro T
    Kokyu To Junkan; 1992 Jul; 40(7):685-90. PubMed ID: 1387724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Streptokinase and urokinase in the treatment of pulmonary thromboemboli; from a national cooperative study.
    Bell WR
    Thromb Haemost; 1976 Feb; 35(1):57-69. PubMed ID: 785689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on thrombolytic therapy for venous thrombosis in the extremities--dynamics of plasmin inhibitor and FDP following administration of urokinase (author's transl)].
    Takeuchi S; Shiba T
    Nihon Geka Hokan; 1979 May; 48(3):354-61. PubMed ID: 157109
    [No Abstract]   [Full Text] [Related]  

  • 12. [Do thrombolytic agents prevent postphlebitis thromboembolism?].
    Trübestein G
    Haemostasis; 1986; 16 Suppl 4():40-53. PubMed ID: 3490419
    [No Abstract]   [Full Text] [Related]  

  • 13. Current developments in thrombolytic therapy.
    Sherry S
    Thromb Diath Haemorrh Suppl; 1973; 56():201-10. PubMed ID: 4617330
    [No Abstract]   [Full Text] [Related]  

  • 14. [Thrombolytic efficacy of a Lys-plasminogen-urokinase combination: studies in experimental animals and humans].
    Latorre J; Foncuberta J; Rosendo A; Elez J
    Angiologia; 1990; 42(6):218-26. PubMed ID: 2075946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of laboratory tests in the diagnosis of venous thromboembolism.
    Sié P
    Haematologica; 1995; 80(2 Suppl):57-60. PubMed ID: 7628772
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of thrombolysis and anticoagulation on the functions of vascular endothelial cells and coagulation and fibrinolysis in patients with pulmonary thromboembolism].
    Peng K; Wang C; Pang BS; Yang YH
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Sep; 28(9):596-9. PubMed ID: 16207425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombolytic therapy.
    Bailey A; Lydon JC; Spielman FJ
    Can Anaesth Soc J; 1985 Jul; 32(4):385-9. PubMed ID: 4027765
    [No Abstract]   [Full Text] [Related]  

  • 18. Thrombolytic therapy for postoperative pulmonary embolism.
    Molina JE; Hunter DW; Yedlicka JW; Cerra FB
    Am J Surg; 1992 Apr; 163(4):375-80; discussion 380-1. PubMed ID: 1558278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thrombolytic treatment of deep venous thrombosis].
    Martínez-Brotons F; Cairols MA
    Sangre (Barc); 1984; 29(4-C):762-6. PubMed ID: 6515512
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of plasma D-dimer in the diagnosis and in the course of fibrinolytic therapy of deep vein thrombosis and pulmonary embolism.
    Knecht MF; Heinrich F; Spanuth E
    Thromb Res; 1992 Jul; 67(2):213-20. PubMed ID: 1440523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.